FDA Starts Releasing Thousands of Pfizer COVID-19 Vaccine Documents

The FDA has begun releasing a court-mandated trove of documents pertaining to the agency’s review of Pfizer/BioNTech’s COVID-19 vaccine — which the agency authorized for emergency use in December 2020 before granting full approval in August 2021.

To View This Article:

Login

Subscribe To FDAnews

Upcoming Events

MAGI@home Clinical Research Conference 2024

Featured Products

• From QSR to QMSR: Meeting FDA’s New Requirements" width="" height="" />

From QSR to QMSR: Meeting FDA’s New Requirements

FDA Oversight of Laboratory-Developed Tests — The Impact of the Final Rule